Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin

Journal of Immunology

Volumn 161, Issue 4, 1998, Pages 2060-2069

  Delhem, Nadirah ^a   Hadida, Fabienne ^b   Gorochov, Guy ^b   Carpentier, Françoise ^c,e   De Cavel, Jean Pierre ^a   Andréani, Jean François ^d   Autran, Brigitte ^b   Cesbron, Jean Yves ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Hopital Victor Provo   (France)

^d Service de Chirurgie Maxillo Faciale   (France)

^e UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 160; INTERLEUKIN 12; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LYMPHOCYTE CULTURE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SKIN TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD1; ANTIGENS, VIRAL; AVIPOXVIRUS; CELL LINE; CELL MOVEMENT; CHIMERA; CYTOKINES; EPITOPES, T-LYMPHOCYTE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; INJECTIONS, INTRADERMAL; LANGERHANS CELLS; LEUKOCYTES; LYMPHOCYTE TRANSFUSION; MICE; MICE, SCID; RECOMBINANT FUSION PROTEINS; SKIN; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TH1 CELLS;

EID: 0032529417     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527.
2. Jeggo, P. A., G. E. Taccioli, and S. P. Jackson. 1995. Menage à trois: double strand break repair, V(D)J recombination and DNA-PK. Bioessays 17:949.
3. Bogue, M., and D. B. Roth. 1996. Mechanism of V(D)J recombination. Curr. Opin. Immunol. 8:175.
4. Mosier, D. E., R. J. Gulizia, S. M. Baird, and D. B. Wilson. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256.
5. McCune, J., H. Kaneshima, J. Krowka, R. Namikawa, H. Outzen, B. Peault, L. Rabin, C. C. Shih, E. Yee, M. Lieberman, I. Weissman and L. Shultz. 1991. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu. Rev. Immunol. 9:399.
6. Mosier, D. E. 1996. Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. In Advances in Immunology, Vol 63. F. J. Dixon, ed. Academic Press, San Diego, CA p. 79.
7. Torbett, B. E., G. Picchio, and D. E. Mosier. 1991. hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunol. Rev. 124: 139.
8. Tary Lehmann, M., A. Saxon, and P. V. Lehmann. 1995. The human immune system in hu-PBL-SCID mice. Immunol. Today 16:529.
9. Saxon, A., E. Macy, K. Denis, L. M. Tary, O. Witte, and J. Braun. 1991. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J. Clin. Invest. 87:658.
10. Abedi, M. R., B. Christensson, K. B. Islam, L. Hammarstrom, and C. I. E. Smith. 1992. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur. J. Immunol. 22:823.
11. Tary Lehmann, M., and A. Saxon. 1992. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J. Exp. Med. 175:503.
12. Neil, G. A., and D. W. Sammons. 1992. Immunization of SCID-Hu mice and generation of anti-hepatitis B surface antigen-specific hybridomas by electrofusion. Hum. Antib. Hybrid. 3:201.
13. Duchosal, M. A., S. A. Eming, P. Fischer, D. Leturcq, C. F. Barbas, P. J. Mcconahey, R. H. Caothien, G. B. Thornton, F. J. Dixon, and D. R. Burton. 1992. Immunization of Hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature 355:258.
14. Aaberge, I. S., T. E. Steinsvik, E. C. Groeng, R. B. Leikvold, and M. Lovik. 1996. Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors. Clin. Exp. Immunol. 105:12.
15. Markham, R. B., and A. D. Donnenberg. 1992. Effect of donor and recipient immunization protocols on primary and secondary human antibody responses in SCID mice reconstituted with human peripheral blood mononuclear cells. Infect. Immun. 60:2305.
16. Hesselton, R. M., R. A. Koup, M. A. Cromwell, B. S. Graham, M. Johns, and J. L. Sullivan. 1993. Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution. J. Infect. Dis. 168:630.
17. Somasundaram, R., L. Jacob, K. Adachi, R. Class, S. Scheck, H. Maruyama, and D. Herlyn. 1995. Limitations of the severe combined immunodeficiency (SCID) mouse model for study of human B-cell responses. Scand. J. Immunol. 41:384.
18. Mazingue, C., F. Cottrez, C. Auriault, J. Y. Cesbron, and A. Capron. 1991. Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells. Eur. J. Immunol. 21:1763.
19. Aaberge, I. S., T. E. Michaelsen, A. K. Rolstad, E. C. Groeng, P. Solberg, and M. Lovik. 1992. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect. Immun. 60:4146.
20. Ifversen, P., C. Martensson, L. Danielsson, C. Ingvar, R. Carlsson, and C. A. Borrebaeck. 1995. Induction of primary antigen-specific immune responses in SCID-hu-PBL by coupled T-B epitopes. Immunology 84:111.
21. Bombil, F., J. P. Kints, J. M. Scheiff, H. Bazin, and D. Latinne. 1996. A promising model of primary human immunization in human-SCID mouse. Immunobiology 195:360.
22. Segall, H., I. Lubin, H. Marcus, A. Canaan, and Y. Reisner. 1996. Generation of primary antigen-specific human CTL in human/mouse radiation chimera. Blood 88:721.
23. Malkovska, V., F. K. Cigel, N. Armstrong, B. E. Storer, and R. Hong. 1992. Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency. Cancer Res. 52:5610.
24. Alegre, M. L., L. J. Peterson, D. R. Jeyarajah, M. Weiser, J. A. Bluestone, and J. R. Thistlethwaite. 1994. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J. Immunol. 153:2738.
25. Bos, J. D., and M. L. Kapsenberg. 1993. The skin immune system: progress in cutaneous biology. Immnuol. Today 14:75.
26. Schmitt, D. 1995. Immune response in the skin. Clin. Rev. Allergy Immunol. 13:77.
27. Kim, Y. H., D. T. Woodley, K. C. Wynn, W. Giomi, and E. A. Bauer. 1992. Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model. J. Invest. Dermatol. 98:191.
28. Yan, H. C., I. Juhasz, J. Pilewski, G. F. Murphy, M. Herlyn, and S. M. Albelda. 1993. Human/severe combined immunodeficient mouse chimeras: an experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J. Clin. Invest. 91:986.
29. Yan, H. C., H. M. Delisser, J. M. Pilewski, K. M. Barone, P. J. Szklut, X. J. Chang, T. J. Ahern, P. Langersafer, and S. M. Albelda. 1994. Leukocyte recruitment into human skin transplanted onto severe combined immunodeficient mice induced by TNF-α is dependent on E-selectin. J. Immunol. 152:3053.
30. Brandsma, J. L., D. G. Brownstein, W. Xiao, and B. J. Longley. 1995. Papilloma formation in human foreskin xenografts after inoculation of human papilloma-virus type 16 DNA. J. Virol. 69:2716.
31. Soballe, P. W., K. T. Montone, K. Satyamoorthy, M. Nesbit, and M. Herlyn. 1996. Carcinogenesis in human skin grafted to SCID mice. Cancer Res. 56:757.
32. Nomura, T., H. Nakajima, T. Hongyo, E. Taniguchi, K. Fukuda, L. Y. Li, M. Kurooka, K. Sutoh, P. M. Hande, T. Kawaguchi, M. Ueda, and H. Takatera. 1997. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice. Cancer Res. 57:2081.
33. Petzelbauer, P., M. Groger, R. Kunstfeld, E. Petzelbauer, and K. Wolff. 1996. Human delayed-type hypersensitivity reaction in a SCID mouse engrafted with human T cells and autologous skin. J. Invest. Dermatol. 107:576.
34. Christofidou Solomidou, M., B. J. Longley, D. Whitaker Menezes, S. M. Albelda, and G. F. Murphy. 1997. Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia. J. Invest. Dermatol. 109:102.
35. Pialoux, G., J. L. Excler, Y. Riviere, G. Gonzalez-Canali, V. Feuillie, P. Coulaud, J. C. Gluckman, T. J. Matthews, B. Meignier, M. P. Kieny, P. Gonnet, and I. Diaz. 1995. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160(MN) followed by a recombinant glycoprotein 160(MN/LAI). AIDS Res. Hum. Retroviruses 11:373.
36. Hadida, F., A. Parrot, M.-P. Kieny, B. Sabat-Sowti, C. Mayaud, P. Debre, and B. Autran. 1992. Carboxy-terminal and central regions of human immunodeficiency virus-1 NEF recognized by CTL from lymphoid organs. J. Clin. Invest. 89:53.
37. Murphy, E., S. Hienry, A. Sher, and A. O'Garra. 1993. Detection of in vivo expression of interleukin 10 using a semiquantitative PCR method in Schistosoma mansoni infected mice. J. Immunol. Methods 162:211.
38. high human thymocytes are activated and already functionally differentiated in helper and cytotoxic cells. J. Immunol. 152:1738.
39. Chomezynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 52.
40. Genevée, C., A. Diu, J. Nicrat, A. Caignard, P. Y. Dietrich, L. Ferradini, S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primer (Vα1-W29/Vβ-W24) for the study of human TCR variable V gene segment usage by PCR. Eur. J. Immunol. 22:1561.
41. Pannetier, C., J. Even, and P. Kourilsky. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16:176.
42. Dick, J. E., T. Lapidot, J. Vormoor, A. Larochelle, D. Bonnet, and J. Wang. 1995. Human hematopoiesis in SCID mice. In Ontogeny of Hematopoiesis, Vol. 235. E. Gluckman and L. Coulombel, eds. Editions Inserm, Paris, France, p. 97.
43. Taghian, A., and P. Huang. 1995. The nude and SCID mice as a tumor model in experimental cancer biology. Cancer J. 8:52.
44. Duchosal, M. A. 1992. SCID mice in the study of human autoimmune diseases. Springer Semin. Immunopathol. 14:159.
45. Jorgensen, C., C. Bologna, and J. Sany. 1995. Autoimmunity: insights provided by the SCID mouse model. Rev. Rhum. Engl. Ed. 62:519.
46. Seydel, K. B., and S. L. Stanley. 1996. SCID and the study of parasitic disease. Clin. Microbiol. Rev. 9:126.
47. Mosier, D. E. 1996. Small animal models for acquired immune deficiency syndrome (AIDS) research. Lab. Anim. Sci. 46:257.
48. + T cell repertoire in hu-PBL-SCID chimeras. J. Exp. Med. 180:1817.
49. Murray, A. G., P. Petzelbauer, C. C. W. Hughes, J. Costa, P. Askenase, and J. S. Pober. 1994. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc. Natl. Acad. Sci. USA 91:9146.
50. Katz, S. I., K. Tamaki, and D. H. Sachs. 1979. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282:324.
51. Mosier, D. E. 1991. Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. Adv. Immunol. 50:303.
52. Fichtelius, K. E., O. Groth, and S. Lidén. 1970. The skin, a first level lymphoid organ? Int. Arch. Allergy 37:607.
53. Chen, F. A., S. S. Williams, W. C. Fanslow, and R. B. Bankert. 1995. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/ CD40 ligand. J. Immunol. 155:2833.
54. Cox, W. I., J. Tartaglia, and E. Paoletti. 1993. Induction of CTL by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. Virology 185:845.
55. + human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. Science 248: 1234.
56. + T cell responses associated with control of viremia. Science 278:1447.
57. Murphy, W. J., K. C. Conlon, T. J. Sayers, R. H. Wiltrout, T. C. Back, J. R. Ortaldo, and D. L. Longo. 1993. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. J. Immunol. 150:3634.
58. Kaul, R., A. Sharma, J. R. Lisse, and P. Christadoss. 1995. Human recombinant IL-2 augments immunoglobulin and induces rheumatoid factor production by rheumatoid arthritis lymphocytes engrafted into severe combined immunodeficient mice. Clin. Immunol. Immunopathol. 74:271.
59. Mosier, D. E., R. J. Gulizia, P. D. Macisaac, L. Corey, and P. D. Greenberg. 1993. Resistance to human immunodeficiency virus-1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc. Natl. Acad. Sci. USA 90:2443.
60. + CTL protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J. Immunol. 153:4826.
61. Riddell, S. R., and P. D. Greenberg. 1995. Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13:545.
62. Albert, S. E., C. McKerlie, A. Pester, B. J. Edgell, J. Carlyle, M. Petric, and J. W. Chamberlain. 1997. Time-dependent induction of protective anti-influenza immune responses in human peripheral blood lymphocyte/SCID mice. J. Immunol. 159:1393.
63. Garcia, S., G. Dadaglio, and M. L. Gougeon. 1997. Limits of the human-PBL-SCID mice model: Severe restriction of the Vβ T-cell repertoire of engrafted human T cells. Blood 89:329.